Selected research
Market Analysis & Forecast
Global Sore Throat Remedies Market Analysis and Forecast 2026-2032
Market perspective
The global Sore Throat Remedies market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Sore Throat Remedies include Sun Pharmaceutical, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer AG, AstraZeneca, Reckitt Benckiser Group and Procter & Gamble, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Sore Throat Remedies, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Sore Throat Remedies, also provides the revenue of main regions and countries. Of the upcoming market potential for Sore Throat Remedies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sore Throat Remedies revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sore Throat Remedies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Sore Throat Remedies revenue, projected growth trends, production technology, application and end-user industry.
Sore Throat Remedies Segment by Company
Sun Pharmaceutical
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Bayer AG
AstraZeneca
Reckitt Benckiser Group
Procter & Gamble
Prestige Brands Holdings
Sore Throat Remedies Segment by Type
Tablets/Pills
Oral Syrup
Lozenges
Others
Sore Throat Remedies Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce/Online Pharmacies
Others
Sore Throat Remedies Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sore Throat Remedies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sore Throat Remedies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sore Throat Remedies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Sore Throat Remedies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Sore Throat Remedies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sore Throat Remedies revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets/Pills
- Oral Syrup
- Lozenges
- Others
Applications
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce/Online Pharmacies
- Others
Companies covered
- Sun Pharmaceutical
- Johnson & Johnson
- Novartis
- Pfizer
- GlaxoSmithKline
- Bayer AG
- AstraZeneca
- Reckitt Benckiser Group
- Procter & Gamble
- Prestige Brands Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Sore Throat Remedies Market by Type
- 1.2.1 Global Sore Throat Remedies Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Tablets/Pills
- 1.2.3 Oral Syrup
- 1.2.4 Lozenges
- 1.2.5 Others
- 1.3 Sore Throat Remedies Market by Application
- 1.3.1 Global Sore Throat Remedies Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 E-Commerce/Online Pharmacies
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sore Throat Remedies Market Dynamics
- 2.1 Sore Throat Remedies Industry Trends
- 2.2 Sore Throat Remedies Industry Drivers
- 2.3 Sore Throat Remedies Industry Opportunities and Challenges
- 2.4 Sore Throat Remedies Industry Restraints
3 Global Growth Perspective
- 3.1 Global Sore Throat Remedies Market Perspective (2021-2032)
- 3.2 Global Sore Throat Remedies Growth Trends by Region
- 3.2.1 Global Sore Throat Remedies Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Sore Throat Remedies Market Size by Region (2021-2026)
- 3.2.3 Global Sore Throat Remedies Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Sore Throat Remedies Revenue by Players
- 4.1.1 Global Sore Throat Remedies Revenue by Players (2021-2026)
- 4.1.2 Global Sore Throat Remedies Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Sore Throat Remedies Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Sore Throat Remedies Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Sore Throat Remedies Key Players Headquarters & Area Served
- 4.4 Global Sore Throat Remedies Players, Product Type & Application
- 4.5 Global Sore Throat Remedies Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Sore Throat Remedies Market CR5 and HHI
- 4.6.3 2025 Sore Throat Remedies Tier 1, Tier 2, and Tier 3
5 Sore Throat Remedies Market Size by Type
- 5.1 Global Sore Throat Remedies Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Sore Throat Remedies Revenue by Type (2021-2032)
- 5.3 Global Sore Throat Remedies Revenue Market Share by Type (2021-2032)
6 Sore Throat Remedies Market Size by Application
- 6.1 Global Sore Throat Remedies Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Sore Throat Remedies Revenue by Application (2021-2032)
- 6.3 Global Sore Throat Remedies Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Sun Pharmaceutical
- 7.1.1 Sun Pharmaceutical Company Information
- 7.1.2 Sun Pharmaceutical Business Overview
- 7.1.3 Sun Pharmaceutical Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.1.4 Sun Pharmaceutical Sore Throat Remedies Product Portfolio
- 7.1.5 Sun Pharmaceutical Recent Developments
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Company Information
- 7.2.2 Johnson & Johnson Business Overview
- 7.2.3 Johnson & Johnson Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.2.4 Johnson & Johnson Sore Throat Remedies Product Portfolio
- 7.2.5 Johnson & Johnson Recent Developments
- 7.3 Novartis
- 7.3.1 Novartis Company Information
- 7.3.2 Novartis Business Overview
- 7.3.3 Novartis Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.3.4 Novartis Sore Throat Remedies Product Portfolio
- 7.3.5 Novartis Recent Developments
- 7.4 Pfizer
- 7.4.1 Pfizer Company Information
- 7.4.2 Pfizer Business Overview
- 7.4.3 Pfizer Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.4.4 Pfizer Sore Throat Remedies Product Portfolio
- 7.4.5 Pfizer Recent Developments
- 7.5 GlaxoSmithKline
- 7.5.1 GlaxoSmithKline Company Information
- 7.5.2 GlaxoSmithKline Business Overview
- 7.5.3 GlaxoSmithKline Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.5.4 GlaxoSmithKline Sore Throat Remedies Product Portfolio
- 7.5.5 GlaxoSmithKline Recent Developments
- 7.6 Bayer AG
- 7.6.1 Bayer AG Company Information
- 7.6.2 Bayer AG Business Overview
- 7.6.3 Bayer AG Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.6.4 Bayer AG Sore Throat Remedies Product Portfolio
- 7.6.5 Bayer AG Recent Developments
- 7.7 AstraZeneca
- 7.7.1 AstraZeneca Company Information
- 7.7.2 AstraZeneca Business Overview
- 7.7.3 AstraZeneca Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.7.4 AstraZeneca Sore Throat Remedies Product Portfolio
- 7.7.5 AstraZeneca Recent Developments
- 7.8 Reckitt Benckiser Group
- 7.8.1 Reckitt Benckiser Group Company Information
- 7.8.2 Reckitt Benckiser Group Business Overview
- 7.8.3 Reckitt Benckiser Group Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.8.4 Reckitt Benckiser Group Sore Throat Remedies Product Portfolio
- 7.8.5 Reckitt Benckiser Group Recent Developments
- 7.9 Procter & Gamble
- 7.9.1 Procter & Gamble Company Information
- 7.9.2 Procter & Gamble Business Overview
- 7.9.3 Procter & Gamble Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.9.4 Procter & Gamble Sore Throat Remedies Product Portfolio
- 7.9.5 Procter & Gamble Recent Developments
- 7.10 Prestige Brands Holdings
- 7.10.1 Prestige Brands Holdings Company Information
- 7.10.2 Prestige Brands Holdings Business Overview
- 7.10.3 Prestige Brands Holdings Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 7.10.4 Prestige Brands Holdings Sore Throat Remedies Product Portfolio
- 7.10.5 Prestige Brands Holdings Recent Developments
8 North America
- 8.1 North America Sore Throat Remedies Revenue (2021-2032)
- 8.2 North America Sore Throat Remedies Revenue by Type (2021-2032)
- 8.2.1 North America Sore Throat Remedies Revenue by Type (2021-2026)
- 8.2.2 North America Sore Throat Remedies Revenue by Type (2027-2032)
- 8.3 North America Sore Throat Remedies Revenue Share by Type (2021-2032)
- 8.4 North America Sore Throat Remedies Revenue by Application (2021-2032)
- 8.4.1 North America Sore Throat Remedies Revenue by Application (2021-2026)
- 8.4.2 North America Sore Throat Remedies Revenue by Application (2027-2032)
- 8.5 North America Sore Throat Remedies Revenue Share by Application (2021-2032)
- 8.6 North America Sore Throat Remedies Revenue by Country
- 8.6.1 North America Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Sore Throat Remedies Revenue by Country (2021-2026)
- 8.6.3 North America Sore Throat Remedies Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Sore Throat Remedies Revenue (2021-2032)
- 9.2 Europe Sore Throat Remedies Revenue by Type (2021-2032)
- 9.2.1 Europe Sore Throat Remedies Revenue by Type (2021-2026)
- 9.2.2 Europe Sore Throat Remedies Revenue by Type (2027-2032)
- 9.3 Europe Sore Throat Remedies Revenue Share by Type (2021-2032)
- 9.4 Europe Sore Throat Remedies Revenue by Application (2021-2032)
- 9.4.1 Europe Sore Throat Remedies Revenue by Application (2021-2026)
- 9.4.2 Europe Sore Throat Remedies Revenue by Application (2027-2032)
- 9.5 Europe Sore Throat Remedies Revenue Share by Application (2021-2032)
- 9.6 Europe Sore Throat Remedies Revenue by Country
- 9.6.1 Europe Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Sore Throat Remedies Revenue by Country (2021-2026)
- 9.6.3 Europe Sore Throat Remedies Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
- 9.6.9 Nordic Countries
10 China
- 10.1 China Sore Throat Remedies Revenue (2021-2032)
- 10.2 China Sore Throat Remedies Revenue by Type (2021-2032)
- 10.2.1 China Sore Throat Remedies Revenue by Type (2021-2026)
- 10.2.2 China Sore Throat Remedies Revenue by Type (2027-2032)
- 10.3 China Sore Throat Remedies Revenue Share by Type (2021-2032)
- 10.4 China Sore Throat Remedies Revenue by Application (2021-2032)
- 10.4.1 China Sore Throat Remedies Revenue by Application (2021-2026)
- 10.4.2 China Sore Throat Remedies Revenue by Application (2027-2032)
- 10.5 China Sore Throat Remedies Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Sore Throat Remedies Revenue (2021-2032)
- 11.2 Asia Sore Throat Remedies Revenue by Type (2021-2032)
- 11.2.1 Asia Sore Throat Remedies Revenue by Type (2021-2026)
- 11.2.2 Asia Sore Throat Remedies Revenue by Type (2027-2032)
- 11.3 Asia Sore Throat Remedies Revenue Share by Type (2021-2032)
- 11.4 Asia Sore Throat Remedies Revenue by Application (2021-2032)
- 11.4.1 Asia Sore Throat Remedies Revenue by Application (2021-2026)
- 11.4.2 Asia Sore Throat Remedies Revenue by Application (2027-2032)
- 11.5 Asia Sore Throat Remedies Revenue Share by Application (2021-2032)
- 11.6 Asia Sore Throat Remedies Revenue by Country
- 11.6.1 Asia Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Sore Throat Remedies Revenue by Country (2021-2026)
- 11.6.3 Asia Sore Throat Remedies Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Sore Throat Remedies Revenue (2021-2032)
- 12.2 SAMEA Sore Throat Remedies Revenue by Type (2021-2032)
- 12.2.1 SAMEA Sore Throat Remedies Revenue by Type (2021-2026)
- 12.2.2 SAMEA Sore Throat Remedies Revenue by Type (2027-2032)
- 12.3 SAMEA Sore Throat Remedies Revenue Share by Type (2021-2032)
- 12.4 SAMEA Sore Throat Remedies Revenue by Application (2021-2032)
- 12.4.1 SAMEA Sore Throat Remedies Revenue by Application (2021-2026)
- 12.4.2 SAMEA Sore Throat Remedies Revenue by Application (2027-2032)
- 12.5 SAMEA Sore Throat Remedies Revenue Share by Application (2021-2032)
- 12.6 SAMEA Sore Throat Remedies Revenue by Country
- 12.6.1 SAMEA Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Sore Throat Remedies Revenue by Country (2021-2026)
- 12.6.3 SAMEA Sore Throat Remedies Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst